Efficacy of transabdominal magnetic field therapy on constipation severity in chronic functional constipation: A randomized controlled trial

dc.authorid0000-0002-9793-3952
dc.contributor.authorElverişli, Gizem Boztaş
dc.contributor.authorÖzkaraoğlu, Dilanur Kutlu
dc.contributor.authorİnce, Büşra
dc.contributor.authorAtaç, Amine
dc.contributor.authorAtılgan, Esra
dc.date.accessioned2026-10-05T11:39:47Z
dc.date.available2026-10-05T11:39:47Z
dc.date.issued2026
dc.departmentFakülteler, Sağlık Bilimleri Fakültesi, Fizyoterapi ve Rehabilitasyon Bölümü
dc.description.abstractObjectives: To evaluate transabdominal magnetic field therapy (MFT) for constipation severity and related outcomes in adults with chronic functional constipation. Methodology: This multicenter, three-arm randomized controlled trial was conducted at Istanbul Medipol University and Istanbul Gedik University, Türkiye, from February 2019 to April 2026. Adults meeting Rome III criteria were randomized to MFT, sham, or standard care (SC) (n=75); 60 completers formed the per-protocol analysis (20/group). MFT was administered at 25-Hz and 30-Gauss for 30 minutes, twice weekly for eight weeks. Sham replicated the procedure without active stimulation; SC received standardized constipation management education. The primary outcome was the Constipation Severity Instrument (CSI) total score. Secondary outcomes assessed bowel habits, defecation time, stool form, and constipation-related quality of life (PAC-QOL). Results: MFT reduced CSI more than SC (mean difference in change [MD], -20.55; 95% CI, -24.97 to -16.13) and sham (MD, -14.40; 95% CI, -18.82 to -9.98; both p<0.001). MFT also improved complete spontaneous bowel movements versus SC (ratio of rate ratios [RRR], 1.57; 95% CI, 1.20-2.05) and sham (RRR, 2.39; 95% CI, 1.87-3.07), and reduced PAC-QOL versus SC (MD, -21.25; 95% CI, -24.09 to -18.41) and sham (MD, -11.60; 95% CI, -14.44 to -8.76; all p≤0.001). No adverse events were observed or reported among completers. Conclusions: Transabdominal MFT was associated with greater short-term improvements in constipation severity, bowel function, and constipation-related quality of life than sham treatment and standard care. Future studies should establish optimal stimulation parameters and evaluate long-term effectiveness and safety.
dc.identifier.citationElverisli, G. B., Ozkaraoglu, D. K., Ince, B., Atac, A., & Atilgan, E. (2026). Efficacy of transabdominal magnetic field therapy on constipation severity in chronic functional constipation: A randomized controlled trial. Pakistan Journal of Medical Sciences, 42(10), 2666–2673.
dc.identifier.doi10.12669/pjms.42.10.19535
dc.identifier.endpage2673
dc.identifier.issn1682024X
dc.identifier.issue10
dc.identifier.scopus2-s2.0-105051852659
dc.identifier.startpage2666
dc.identifier.urihttps://hdl.handle.net/20.500.12941/465
dc.identifier.volume42
dc.identifier.wosqualityQ2
dc.indekslendigikaynakScopus
dc.indekslendigikaynakWeb of Science
dc.institutionauthorÖzkaraoğlu, Dilanur Kutlu
dc.institutionauthorid0000-0002-9793-3952
dc.language.isoen
dc.publisherProfessional Medical Publications
dc.relation.ispartofPakistan Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectConstipation
dc.subjectGastrointestinal Motility
dc.subjectMagnetic Field Therapy
dc.subjectQuality of Life
dc.titleEfficacy of transabdominal magnetic field therapy on constipation severity in chronic functional constipation: A randomized controlled trial
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Efficacy of transabdominal magnetic field therapy.pdf
Boyut:
1005.56 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: